US Patent Issued to HALOZYME on July 14 for "Combination therapy with antibody-drug conjugates and hyaluronidases" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,492, issued on July 14, was assigned to HALOZYME INC. (San Diego).

"Combination therapy with antibody-drug conjugates and hyaluronidases" was invented by Robert Connor (San Diego), David Kang (San Diego), Tara Nekoroski (San Diego) and Michael Labarre (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are combination dosing regimens comprising administering an antibody-drug conjugate and hyaluronidase. Combinations and compositions containing the antibody-drug conjugate and hyaluronidase are provided. The dosing regimens and combinations are for treating or preventing cancer."

The patent was filed on Sept. 2, 2025, under Application...